Modifiers of risk of hereditary breast and ovarian cancer
- 1 February 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (2) , 113-123
- https://doi.org/10.1038/nrc726
Abstract
Hereditary breast and ovarian cancer is among the most commonly encountered adult genetic disease, and it is increasingly important that geneticists, oncologists, surgeons and gynaecologists are aware of the issues regarding risk assessment, prevention and management of women with inherited susceptibility to cancer. Genetic risk can be modified by external factors, but what are these factors, and how might our knowledge of them help us to better define the risks for individual women and to develop strategies for cancer prevention?Keywords
This publication has 65 references indexed in Scilit:
- A Genetic Epidemiological Study of Carcinoma of the Fallopian TubeGynecologic Oncology, 2001
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerAmerican Journal of Human Genetics, 2000
- Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2The Lancet, 1999
- Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer PatientsAmerican Journal of Human Genetics, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- A polymorphic stop codon in BRCA2Nature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Influence of age and parity on the development of the human breastBreast Cancer Research and Treatment, 1992